ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
7.60
+1.48 (24.18%)
At close: Jun 20, 2025, 4:00 PM
7.57
-0.03 (-0.39%)
After-hours: Jun 20, 2025, 7:47 PM EDT
ImmuCell Employees
As of December 31, 2024, ImmuCell had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees decreased by 4 or -5.06% compared to the previous year.
Employees
75
Change (1Y)
-4
Growth (1Y)
-5.06%
Revenue / Employee
$364,037
Profits / Employee
-$3,624
Market Cap
68.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ICCC News
- 15 days ago - ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders - GlobeNewsWire
- 5 weeks ago - ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025 - GlobeNewsWire
- 5 weeks ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 - GlobeNewsWire
- 2 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 - GlobeNewsWire
- 2 months ago - ImmuCell Announces Initiation of Investigational Product Use of Re-Tain® - GlobeNewsWire
- 4 months ago - ImmuCell Corporation (ICCC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024 - GlobeNewsWire